Bipolar Disorder vs Borderline Personality Disorder: How Clinicians Distinguish Them
Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Bipolar disorder and borderline personality disorder (BPD) can both involve intense emotional changes, impulsivity, disturbed relationships, depression, and suicidal thoughts. Their overlap makes clinical assessment challenging, especially when a person is evaluated during a crisis. Clinicians distinguish them by reconstructing the pattern of symptoms over time, looking for distinct periods of mood and energy change, and assessing whether interpersonal, identity, and emotion-regulation difficulties persist across different situations. A person's experience deserves careful assessment regardless of the eventual diagnosis. These priorities follow NICE guidance on bipolar disorder, the American Psychiatric Association's BPD practice guideline, and a systematic review directly comparing the two conditions.
Bipolar illness requires evidence of mania or hypomania in its diagnostic history. BPD involves a broader pattern of difficulties with emotional reactivity, interpersonal functioning, self-image, and sometimes impulsivity or self-injury. Neither rapidly changing moods nor a difficult relationship alone establishes either diagnosis. Some people meet criteria for both, and each needs independent evaluation. NIMH on bipolar disorder; NIMH on borderline personality disorder.
For additional clinical context, see How Is Bipolar Disorder Diagnosed? Clinical Assessment Explained, Bipolar Depression vs Major Depression: Diagnosis and Treatment Differences and Bipolar Disorder vs ADHD: Mood Episodes and Persistent Attention Symptoms.
The essential clinical difference
A bipolar mood episode is a recognizable departure from the person's usual mood and functioning, accompanied by altered energy or activity and additional symptoms. The most diagnostically distinctive episodes involve mania or hypomania, although depression is often the reason someone first seeks treatment. Clinicians consider episode duration, intensity, sleep, activation, consequences, and the person's baseline. BPD is identified through a pervasive pattern, generally beginning by early adulthood, of instability in relationships, identity, emotion regulation, and behavior that causes substantial distress or impairment. The word 'pervasive' points to how symptoms recur across situations and periods of life, not to an immutable personality. NIMH bipolar publication; NIMH BPD publication.
The familiar summary that bipolar mood changes last days or weeks whereas BPD changes last hours can be a useful starting question, but it is too crude to function as a diagnostic rule. Stress can precipitate a bipolar episode, bipolar symptoms may remain between episodes, and distress associated with BPD can persist beyond a single day. Clinicians consider the entire syndrome, including sleep, energy, behavior, baseline changes, relationship patterns, and context. Comparative evidence describes meaningful overlap as well as characteristic differences. Massó Rodriguez et al., systematic review.
Bipolar I, bipolar II, and borderline personality disorder: what the names mean
Bipolar I disorder and mania
Bipolar I disorder is defined by at least one manic episode. Mania includes abnormally elevated, expansive, or irritable mood together with increased activity or energy and related symptoms such as decreased need for sleep, unusually pressured speech, racing thoughts, inflated self-esteem or grandiosity, distractibility, accelerated goal-directed behavior, and risky decisions. Under commonly used DSM criteria, the episode lasts at least one week or any duration when hospitalization is necessary; marked impairment, hospitalization, or psychotic features distinguish mania from hypomania. Depression frequently occurs but is not required for bipolar I diagnosis. NIMH's clinical overview; NICE CG185.
Bipolar II disorder and hypomania
Bipolar II disorder requires a lifetime history of at least one hypomanic episode and at least one major depressive episode, without a manic episode. Hypomania usually lasts at least four consecutive days under DSM criteria and is a clear, observable shift in mood, energy, and functioning, yet lacks the severe impairment, hospitalization, or psychosis that qualifies an episode as mania. Bipolar II can produce prolonged, severe depression and major disruption of functioning. It is not a universally 'milder' version of bipolar I. A clinician carefully distinguishes hypomania from an ordinary period of high motivation, relief after depression, ADHD-related activation, or sleep deprivation. NIMH; VA/DoD bipolar guideline, 2023.
Borderline personality disorder
BPD is a clinical diagnosis describing a sustained and impairing pattern that can include intense fear of real or perceived abandonment, unstable relationships, marked shifts in self-image, impulsive behavior, recurrent self-harm or suicidal behavior, emotional reactivity, chronic emptiness, intense anger, and temporary stress-related dissociation or suspiciousness. Any one feature can also occur outside BPD. Clinicians assess whether the complete pattern reaches diagnostic criteria and causes distress or impairment. BPD is treatable; the diagnosis does not imply that someone lacks agency, attachment capacity, or potential for recovery. APA BPD practice guideline, 2024; NIMH BPD overview.
How clinicians compare symptoms and patterns
1. Mood duration: discrete episodes and recurrent emotional reactivity
During mania or hypomania, the person experiences a clearly defined interval of mood and energy change that can be traced across consecutive days. People around them may notice that they are unusually energized, expansive, irritable, restless, talkative, or behaviorally disinhibited compared with their own usual baseline. Bipolar depression may last much longer and obscure memories of earlier activation. In BPD, intense emotions may fluctuate quickly in response to relational and other stressors, including perceived rejection, conflict, or separation, within a pattern extending over months or years. The timing of symptoms matters because it helps place them in a history rather than treating isolated episodes of distress as diagnoses. NICE assessment guidance; systematic cross-diagnostic review.
Neither disorder is diagnosed by watching a single emotional change. A manic episode may begin after a major life event, and a person with BPD may experience sustained depression due to a co-occurring depressive disorder. Clinicians examine whether apparent activation includes the distinctive bipolar syndrome of changed energy and sleep; whether identity, attachment, and relational problems continue during stable mood periods; and whether substances or medical conditions could explain events. NICE recommendations.
2. Increased energy and reduced need for sleep
Reduced need for sleep is a particularly important element of a possible hypomanic or manic episode. A person who previously needed eight hours may sleep only two or three hours and still feel unusually alert, energized, and ready to pursue many plans. This differs from insomnia, in which a person wants to sleep but struggles to do so, often feeling exhausted the following day. Clinicians ask how the sleep change developed, whether it persisted alongside increased activity and altered speech or thinking, and whether observers noticed the same shift. Sleep disruption by itself occurs across many disorders, including BPD, anxiety, PTSD, and depression. NIMH bipolar publication.
Not every person in mania reports a euphoric mood. Severe irritability, rapid speech, agitation, escalating activity, and impaired judgment can dominate the presentation. Similarly, many people with BPD have insomnia, sleep irregularity, anger, or periods of high emotional arousal. A careful clinician looks at their combination, continuity, impact, and change from baseline. VA/DoD bipolar clinical practice guideline; NICE CG185.
3. Interpersonal sensitivity and identity
Clinicians assessing BPD attend to persistent distress around actual or anticipated abandonment, marked swings in how close relationships are perceived, and a fluctuating or unstable sense of self. Chronic emptiness, shame, dissociation under stress, and recurrent conflict may add context when they form a coherent long-term pattern. This assessment should be collaborative and free from character judgments. In bipolar illness, interpersonal problems may arise during depression, mania, impulsive behavior, or the recovery period. Relationship conflict can therefore be a consequence of mood episodes rather than an independent pattern, though both patterns may coexist. NIMH BPD guidance; APA BPD guidance.
One practical question is what remains during sustained periods outside clear mood episodes. When someone reports years of recurrent relationship instability and identity distress even when mood activation is absent, that history prompts assessment for BPD and related conditions. When these difficulties intensify mainly during episodes of altered sleep, activity, and mood, clinicians investigate a bipolar explanation. These are directions for clinical inquiry, not a binary diagnostic test. Comparative systematic review.
4. Impulsivity, anger, and risk taking
Both conditions can be associated with impulsive spending, substance use, sexual decisions, self-injury, anger, and other behaviors with harmful consequences. In bipolar disorder, a marked escalation of risk taking may be linked to a discrete manic or hypomanic episode, particularly if accompanied by less sleep and unusually high energy. BPD-related impulsivity can recur in response to distress, conflicts, or perceived rejection and may appear between depressive or activated episodes. ADHD, trauma-related symptoms, and substance use can contribute to either presentation. In comparative studies, state-related activation and more enduring impulsivity can be informative but overlap is substantial. Massó Rodriguez et al..
Because risky actions carry a high personal and social cost, clinicians ask about their antecedents, function, time course, associated thoughts, and aftermath without presuming intent or moral responsibility from a diagnosis. Violence and dangerousness should never be assumed from either diagnostic label. NIMH BPD publication; NICE bipolar care guidance.
5. Depression, emptiness, and suicidal distress
Depression occurs in bipolar I and bipolar II disorders, and a major depressive episode may look similar at one visit whether it is unipolar or bipolar. The key historical questions concern previous mania or hypomania, family history, medication or substance effects, and the longitudinal course. A person with BPD may also experience depression, persistent dysphoria, grief, emptiness, or an independent mood disorder. Suicidal ideation or self-injury can occur in both conditions and across many other diagnoses. Each warrants attentive assessment on its own merits. NIMH bipolar overview; NIMH BPD overview.
6. Dissociation and psychotic symptoms
Transient dissociation or stress-associated paranoid ideation may occur in BPD, while psychotic features can emerge during severe mania or depression. Clinicians ask about duration, intensity, reality testing, whether the symptoms are confined to mood episodes, and alternative explanations such as substances, medications, or primary psychotic disorders. Psychosis or severe loss of judgment can require urgent assessment irrespective of an existing BPD diagnosis. NICE bipolar assessment and crisis guidance; APA BPD practice guideline.
7. Functioning between symptomatic periods
Some people with bipolar disorder return near their baseline between discrete episodes; others experience residual mood symptoms, sleep problems, or cognitive and functional difficulties. People with BPD may have a prolonged course of relational and emotion-regulation difficulties, but symptoms and functioning can improve substantially with structured treatment and life changes. A clinician considers several years of history rather than assuming that all bipolar symptoms disappear between episodes or that BPD symptoms remain static. NIMH bipolar publication; NIMH BPD publication.
Why clinicians sometimes mistake one disorder for the other
Diagnostic uncertainty is common when assessment occurs during a severe depressive episode, self-harm crisis, emergency visit, or period of intense interpersonal stress. A patient may describe 'mood swings' without ever being asked whether their energy, sleep requirement, and goal-directed activity changed for several consecutive days. Conversely, a clinician focused on rapid emotional shifts may overlook years of unstable identity and relationships. Because hypomania sometimes feels productive rather than problematic, patients may forget to report it until specifically asked. NICE bipolar assessment recommendations; VA/DoD 2023.
Research has documented diagnostic confusion in clinical samples. A study of psychiatric outpatients by Ruggero and colleagues associated borderline personality disorder with prior reported bipolar misdiagnosis; it did not establish a universal rate of misdiagnosis for every care setting. Other cross-diagnostic research finds overlapping depressive, impulsive, emotional, and neurobiological characteristics, making simple rules unreliable. A systematic review of clinical and neuropsychological differences supports a broad, longitudinal differential. Diagnostic labels should be revised when new evidence substantially changes the clinical formulation.
How a careful diagnostic assessment works
A lifetime chronology rather than a snapshot
The clinician reconstructs the earliest significant symptoms and their course: episodes of depression, possible mania or hypomania, changes in sleep and activity, relationship difficulties, identity concerns, self-injury, substance use, medication exposures, major life events, and functioning at school, work, and home. Dates and approximate durations are valuable, but the description of the complete syndrome matters more than a stopwatch. The clinician asks what the person was like before and after a possible episode and whether changes were noticed by others. NICE recommendation 1.3.2 calls for a full history of mood, overactivity, behavior, and functioning, together with a relevant family history.
When appropriate and with the patient's consent, a family member, close friend, or prior record may help reconstruct elevated or activated periods that were not recognized as abnormal. This is particularly useful where major depression dominated treatment encounters. Collateral information informs clinical judgment while respecting confidentiality and the patient's own account. Symptoms may also need to be followed prospectively before a diagnosis can be established confidently. NICE CG185; VA/DoD guideline.
Assessing long-standing interpersonal and self-related patterns
The developmental assessment explores emotional sensitivity, responses to separation or rejection, the stability of relationships, enduring self-image and identity difficulties, chronic emptiness, impulsive coping, and any history of dissociation or trauma. These questions are asked without presuming that childhood adversity proves BPD. Many risk factors are shared across mental-health conditions, and neither a trauma history nor the absence of trauma determines the diagnosis. A meta-review of risk factors in emerging bipolar disorder and BPD found overlapping risk signals and important methodological limitations.
Evaluating other possible explanations
A differential diagnosis must consider major depressive disorder, ADHD, PTSD and other trauma-related conditions, anxiety disorders, substance use and substance-induced mood symptoms, sleep and circadian disruption, psychotic disorders, and relevant medical or neurologic conditions. Thyroid dysfunction and medication effects are examples of factors that may need assessment in a suspected manic presentation. Co-occurring conditions are common, so the question is not always which single diagnosis is 'correct' but whether each proposed syndrome has independent evidence. NICE bipolar recommendations explicitly identify several psychiatric and medical differential diagnoses.
Screening tools: the MDQ and MSI-BPD
The Mood Disorder Questionnaire (MDQ) is a screening instrument that asks about experiences associated with bipolar disorder; the McLean Screening Instrument for BPD (MSI-BPD) screens for borderline-related features. Screening scores can indicate what merits further clinical interview, but positive scores are not a diagnosis, and a high score on one tool does not exclude the other disorder. Sensitivity and specificity depend on the population, threshold, reference standard, and clinical setting. A 2021 comparative study of MDQ and MSI-BPD responses found some symptom items discriminated between diagnoses in its inpatient sample, but relied on clinical discharge diagnoses and was not a universal diagnostic validation.
The original MSI-BPD validation study supports the scale's use as a screening measure under studied conditions, not as an online diagnostic verdict. NICE explicitly advises against questionnaires in primary care to identify bipolar disorder, favoring a detailed clinical assessment and referral when warranted. If a questionnaire raises concern, the appropriate next step is a clinician-led conversation about history, functional impact, and competing explanations. NICE CG185.
Two clinical examples show the importance of the timeline
Imagine a person who, after a long period of usual functioning, develops ten consecutive days of dramatically reduced need for sleep, unusual energy, rapid speech, new grandiose projects, and major uncharacteristic spending, with serious occupational consequences. A relationship stressor may have happened first, but the full pattern calls for assessment of a possible manic episode and its medical, medication-related, and substance-related differentials. This hypothetical example illustrates the pattern prompting bipolar assessment; it cannot establish a diagnosis without a clinician evaluating the person. NIMH bipolar description.
Consider someone who reports many years of severe reactions to anticipated abandonment, intense relationship ruptures, shifting self-image, chronic emptiness, and recurrent impulsive behavior when emotionally overwhelmed, without a verifiable period of sustained mood-and-energy activation. A clinician would assess BPD and other explanations, including depression, trauma-related difficulties, and ADHD. If that same person has a well-documented hypomanic episode, the clinician must also consider bipolar II disorder rather than forcing every symptom into one label. NIMH BPD description; NICE bipolar differential guidance.
Can someone have both bipolar disorder and BPD?
Yes. The diagnoses are compatible when each disorder independently meets its criteria. A person may experience characteristic hypomanic or manic episodes while also having enduring difficulties with identity, relationships, emotional sensitivity, or self-injury that persist beyond mood episodes. Clinicians should assess the episodic and pervasive patterns separately, then formulate care that addresses both. NIMH's BPD overview lists bipolar disorder among conditions that may co-occur with BPD; the cross-diagnostic systematic review describes substantial clinical overlap.
Studies of co-occurrence vary considerably in sampling, setting, definitions, and diagnostic methods. A percentage from a specialized inpatient sample should not be presented as the general population rate. The immediate clinical priorities are understanding each syndrome, reducing suicide and self-harm risk, stabilizing any severe mood episode, addressing interpersonal distress, and improving daily functioning. Diagnostic certainty may be built through repeated assessments rather than a single consultation. VA/DoD guideline; APA BPD practice guideline.
Treatment differences: why the distinction matters
Bipolar treatment is tailored to the phase of illness
Acute mania, bipolar depression, and maintenance prevention of relapse have distinct treatment goals and evidence bases. Depending on the subtype and presentation, treatment may include lithium, selected antipsychotics, lamotrigine, or other medications, with psychoeducation, psychotherapy, regular sleep patterns, and relapse planning as important components. An intervention supported for one phase is not automatically effective for the others. The CANMAT/ISBD evidence update and 2023 VA/DoD practice guideline distinguish these phases and their evidence.
Medication decisions require monitoring and individualized risk-benefit assessment. Lithium entails monitoring of serum concentrations, renal function, thyroid function, hydration, toxicity risks, and important interactions. Lamotrigine requires carefully managed titration and awareness of serious rash. Valproate carries important reproductive and fetal risks, as well as liver and other safety issues. Some antipsychotics require metabolic and neurological monitoring. Antidepressants in bipolar illness need particular caution in view of switching and activation risk; antidepressant monotherapy is generally avoided in bipolar I depression. Clinicians select and review treatments according to episode type, comorbidities, medical history, and patient goals. NICE medication guidance; CANMAT/ISBD 2023.
Structured psychotherapy is central for BPD
For BPD, structured psychological treatment is the central approach. Dialectical behavior therapy (DBT) has an evidence base for several relevant outcomes; mentalization-based therapy, schema therapy, and other specialist models may also be appropriate according to the patient's needs and service availability. Treatment can address emotional regulation, self-harm, relationships, self-image, and functioning. It should be delivered within a clear, collaborative plan. A Cochrane systematic review of psychological therapies for BPD and the APA BPD practice guideline support structured, evidence-informed psychotherapy while recognizing variation in study quality and results.
Medication is not an established primary treatment for BPD as a whole. NICE advises against prescribing medication specifically for BPD or its individual symptoms and against medium- or long-term antipsychotic use for BPD alone. Appropriate pharmacotherapy can still be indicated for independently diagnosed co-occurring conditions such as bipolar disorder, or in carefully defined short-term clinical situations. A person with both diagnoses may need coordinated psychiatric treatment and specialist psychotherapy. NICE CG78; APA BPD guideline.
If diagnoses are uncertain or both are present
The treatment team should identify which symptoms are part of a discrete mood episode, which appear between episodes, and what outcomes matter to the patient. Monitoring may address mood recurrence, sleep, depression, self-harm risk, physical adverse effects, relationship functioning, and recovery goals. Treatment response cannot by itself prove a diagnosis: an antipsychotic may reduce agitation across diagnoses, and psychotherapy may improve emotional regulation without deciding whether bipolar illness is present. A specialist second opinion can be appropriate when the history is complex or previous diagnoses conflict. VA/DoD bipolar guideline; APA BPD guideline.
Do not start, stop, or alter prescribed psychiatric medication based on an online comparison, an MDQ score, or a suspicion that an earlier diagnosis was mistaken. Some abrupt medication changes can precipitate withdrawal effects or a return of severe symptoms. Review the indication, adverse effects, monitoring plan, and any proposed changes directly with the prescriber. NICE CG185.
What the scientific evidence does and does not establish
The clinical literature supports the value of a documented manic or hypomanic syndrome for identifying bipolar illness, together with a broader, cross-situational pattern of emotion-regulation, relationship, and identity difficulties when assessing BPD. A 2016 differential diagnosis study by Bayes and colleagues found combinations of clinical variables informative in its sample, but no single question should be treated as a universal classifier. A 2021 systematic review identified group-level differences across symptoms, cognition, and neuroimaging while emphasizing heterogeneity, overlapping characteristics, and limited clinical utility of biomarkers for distinguishing an individual patient.
A meta-review of 22 reviews and meta-analyses on developmental risks described overlap in early adversity and other risk factors; risk factors are not diagnostic criteria. Neither family history, childhood trauma, a brain scan, nor a questionnaire can independently certify either condition. The evidence base is also constrained by varying diagnostic interviews, referral patterns, sample size, and the frequent exclusion of complex comorbidity from studies. Good clinical assessment makes those limitations explicit and can revisit an uncertain diagnosis as the longitudinal course becomes clearer.
When to seek urgent assessment
Seek prompt urgent help for suspected severe mania, rapidly increasing activation with little sleep, psychotic symptoms, markedly impaired judgment, dangerous behavior, extreme agitation, inability to care for basic needs, or suicidal thoughts accompanied by intent, a plan, or immediate danger. Self-harm, repeated crises, or increasing suicidal distress deserve assessment regardless of whether bipolar disorder, BPD, both, or another condition is suspected. In an immediate emergency, call your local emergency number or go to an emergency department. In the United States, the 988 Suicide & Crisis Lifeline is available by calling or texting 988. NICE bipolar crisis recommendations; NIMH BPD safety information.
When immediate danger is absent, arrange an assessment with a qualified mental-health clinician who can investigate bipolar episodes as well as personality, trauma-related, substance-related, and other explanations. If a new medication coincides with marked activation, increasingly reduced sleep, or loss of judgment, contact the prescribing clinician promptly instead of independently changing the regimen. VA/DoD guideline.
Preparing for a clinical appointment
Bring a timeline showing approximate start and end dates of unusual periods of elevated or irritable mood, increased energy, reduced need for sleep, and depression. Record major functional effects, changes noticed by others, stressors and relationship events, periods when you felt more stable, self-harm concerns, and previous assessment or hospitalization dates. Include medications, substance use, sleep history, and what happened during previous treatment trials. If appropriate and acceptable, ask whether a trusted person can contribute their observations. This follows the priorities of NICE clinical assessment guidance.
Questions worth asking include: 'What specifically supports a manic or hypomanic episode in my history?'; 'Which symptoms have continued between mood episodes?'; 'How did you evaluate identity and relationship patterns?'; 'Could both conditions apply?'; 'What else could explain these symptoms?'; 'Which treatment decisions depend on this distinction?'; and 'What warning signs should prompt urgent contact?' Clinicians may have a clear working formulation at the first visit, but more complex presentations often benefit from records, collateral history, structured assessment, and follow-up.
Common misconceptions
'Any mood swing is bipolar' is inaccurate: bipolar diagnoses require a distinct clinical mood-and-energy syndrome. 'BPD means moods change every hour' reduces a multifaceted disorder to one possible symptom. 'Bipolar II is mild' ignores the severity of many depressive episodes. 'A history of childhood trauma proves BPD' mistakes an associated risk factor for a diagnostic rule. 'Self-harm proves BPD' ignores its occurrence across diagnoses. 'BPD cannot improve' conflicts with evidence that structured psychological treatment can help. The correct questions concern the full diagnostic pattern, impairment, co-occurrence, and response to care over time. NIMH bipolar; NIMH BPD; Cochrane psychotherapy review.
Frequently asked questions
Are bipolar disorder and borderline personality disorder the same thing?
They are distinct diagnoses with overlapping symptoms. Bipolar illness requires a history of mania or hypomania; BPD involves a pervasive clinical pattern involving emotional, relational, self-image, and behavioral difficulties. Both can occur in one person. NIMH bipolar; NIMH BPD.
Can BPD produce a manic episode?
BPD can involve agitation, impulsivity, irritability, and intense emotions that superficially resemble some manic features. A true manic episode requires a distinct clinical syndrome of mood and energy change and its own differential assessment. If one occurs, bipolar disorder, a medication or substance effect, or another cause may require evaluation. NICE CG185.
Is the difference simply hours versus days?
No. The typical duration of mood changes can provide a clue, but clinicians rely on the accompanying energy and sleep changes, episode boundaries, degree of impairment, interpersonal and self-image patterns, and other diagnoses. Cross-diagnostic systematic review.
Can someone have bipolar II disorder and BPD together?
Yes. Bipolar II requires hypomania and major depressive episodes without mania. BPD can coexist if its separate long-term clinical pattern is established. Depression, irritability, or relationship conflict alone cannot verify either one. NIMH BPD overview.
Which condition is linked with fear of abandonment?
Intense fear of real or perceived abandonment is a characteristic possible feature of BPD within the broader diagnostic pattern. People without BPD can also experience abandonment concerns, including in anxiety, trauma-related, and mood disorders. A clinician considers history and functioning rather than using this one feature as proof. NIMH BPD.
Can questionnaires tell which disorder I have?
Questionnaires such as the MDQ and MSI-BPD are screening aids. Their accuracy varies by population and context, and they cannot replace a lifetime clinical interview or confidently separate overlapping conditions on their own. Comparative screening study; NICE CG185.
What if the first diagnosis was wrong?
Request a structured review of previous periods of unusually high energy, low sleep need, depression, long-standing relational and self-image difficulties, medical or substance effects, and medication responses. Ask how alternative conditions and co-occurrence were considered. Seek a specialist second opinion when uncertainty persists and keep prescribed medication changes under clinician supervision. VA/DoD 2023.
Does the treatment change if I have both diagnoses?
Care usually integrates phase-specific bipolar management with psychotherapy targeting persistent BPD-related difficulties, along with individualized safety planning and monitoring. Medication indicated for bipolar disorder is not automatically a treatment for BPD itself. NICE bipolar; NICE BPD; APA BPD guideline.
Related Articles
For further evidence-based comparison of overlapping clinical presentations, see OCD vs Bipolar Disorder: Obsessions, Mood Episodes, Repetition, and Insight, OCD and Bipolar Disorder: Comorbidity, Diagnosis, Medication, and Treatment, and Neuroticism and Bipolar Disorder: Associations, State Effects, and Limits. These published English Hub articles address distinct clinical and conceptual questions. Links to the EN-02 parent diagnostic article, neighboring differential guides, and the EN-13 BPD topic can be added when those pages are published.
References
American Psychiatric Association. (2024). The American Psychiatric Association practice guideline for the treatment of patients with borderline personality disorder (2nd ed.). Official guideline and DOI.
Bayes, A. J., McClure, G., Fletcher, K., Román Ruiz del Moral, Y. E., Hadzi-Pavlovic, D., Stevenson, J. L., Manicavasagar, V. L., & Parker, G. B. (2016). Differentiating the bipolar disorders from borderline personality disorder. Acta Psychiatrica Scandinavica, 133(3), 187–195. DOI: 10.1111/acps.12509.
Durdurak, B. B., Altaweel, N., Upthegrove, R., & Marwaha, S. (2022). Understanding the development of bipolar disorder and borderline personality disorder in young people: A meta-review of systematic reviews. Psychological Medicine. DOI: 10.1017/S0033291722003002.
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. DOI: 10.1176/appi.focus.20230009.
Massó Rodriguez, A., et al. (2021). Clinical features, neuropsychology and neuroimaging in bipolar and borderline personality disorder: A systematic review of cross-diagnostic studies. Frontiers in Psychiatry, 12, 681876. DOI: 10.3389/fpsyt.2021.681876.
National Institute for Health and Care Excellence. (2009). Borderline personality disorder: Recognition and management (CG78). Official recommendations.
National Institute for Health and Care Excellence. (2014; subsequently updated). Bipolar disorder: Assessment and management (CG185). Official recommendations.
National Institute of Mental Health. (n.d.). Bipolar disorder. Official publication.
National Institute of Mental Health. (n.d.). Borderline personality disorder. Official publication.
Palmer, B. A., Pahwa, M., Geske, J. R., Kung, S., Nassan, M., Schak, K. M., Alarcon, R. D., Frye, M. A., & Singh, B. (2021). Self-report screening instruments differentiate bipolar disorder and borderline personality disorder. Brain and Behavior. PubMed: 34056864.
Ruggero, C. J., Zimmerman, M., Chelminski, I., & Young, D. (2010). Borderline personality disorder and the misdiagnosis of bipolar disorder. Journal of Psychiatric Research, 44(6), 405–408. DOI: 10.1016/j.jpsychires.2009.09.011.
Storebø, O. J., et al. (2020). Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews. PubMed: 32368793.
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for the management of bipolar disorder. Official guideline.
Zanarini, M. C., et al. (2003). A screening measure for BPD: The McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). Journal of Personality Disorders. PubMed: 14744082.